Lisa A. Mandl, MD, MPH
Rheumatology
Lisa A. Mandl, MD, MPH
Dr. Lisa Mandl specializes in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and osteoarthritis. She is actively involved in research in these areas, and has been funded by many organizations including the National Institutes of Health.
She has published numerous articles in peer reviewed journals and regularly presents her work at national and international meetings. She has received awards for teaching excellence, and is also actively involved in teaching fellows, residents and medical students.
Dr. Mandl received her MD and Internal Medicine residency training at the University of British Columbia in Vancouver, British Columbia. She received her fellowship training in Rheumatology at The Brigham and Women’s Hospital /Harvard Medical School in Boston, Massachusetts. She also received a Master’s in Public Health from Harvard School of Public Health.
Patient Stories
Appointments
Assistant Attending Physician, Hospital for Special Surgery
Assistant Research Professor of Medicine, Weill Cornell Medical College
Assistant Research Professor of Public Health, Weill Cornell Medical College
Departments
Specialized Centers
Special Expertise
Rheumatoid Arthritis
Psoriatic Arthritis
Osteoarthritis
Affiliations
Member, Osteoarthritis Research Society International
Member, Arthritis Foundation
Fellow, Royal College of Physicians and Surgeons of Canada
Languages
English
Insurance Information
Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may have coverage subject to the availability of 'out-of-network' benefits.
Patient ratings for Dr. Mandl
Industry Relationships
One of the goals of HSS is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
Below are the healthcare industry relationships reported by Dr. Mandl as of December 17, 2019.
- Annals of Internal Medicine - Associate Editor
- Regeneron Pharmaceuticals, Inc. - Research Support
- UpToDate - Author
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
Patients should feel free to ask their HSS physicians questions about these relationships.
Dr. Mandl in the News
- Lupus Patients Endorse PROMIS Assessment Tool as Relevant and Valuable
- Systemic lupus erythematosus: The promise of PROMIS — is it ready for prime time in SLE?
- Online treatment reduces chronic knee pain from arthritis
- Hip Surgery Safe, Effective in Psoriatic Arthritis
- Top 9 Arthritis Signs: Do You Have Them?
- Knee Arthritis Drugs Beat Placebos, but Study Finds No Clear Winner
- Presence of Family May Lessen Pain
- Social Isolation Linked to More Pain After Hip Replacement
- Study: People Who Are Socially Isolated Experience More Pain After Hip Replacement
- Expensive Arthritis Treatment No Better Than Steroid Therapy - 2013
- Study Assesses Impact of Rheumatoid Arthritis on Joint Replacement Surgery Outcomes
- Keeping Hands in Working Order
- New, less expensive treatment for arthritis
- Expensive Arthritis Treatment Not Worth It?
- Expensive Arthritis Treatment No Better Than Steroid Therapy - 2012
- Researchers Identify Impact of Rheumatoid Arthritis and Lupus on Joint Replacement Surgery Outcomes
- Study Overturns Common Assumption About Knee Replacements in Morbidly Obese Individuals
- Changing rheumatoid arthritis medication stop time may help reduce flare-ups
- Treatments for Hand Arthritis
- Hospital for Special Surgery Scientists Share Advances in Lupus and Related Conditions
- Heavy Birth Weight Increases Risk of Developing Rheumatoid Arthritis
- ACL Reconstruction Study Finds Surgery On The Rise
- Rheumatoid arthritis patients display low expectations for knee replacement
- Tweaking Withdrawal of Rheumatoid Arthritis Medications Before Surgeries May Reduce Disease Flares
- How to Prevent and Treat Arthritis
- Rheumatoid arthritis may be a bigger risk for big babies
- Registries Help Hospitals Keep Tabs on Patients with Joint Replacements
- Rheumatoid Arthritis Patients Have Low Expectations After Knee Replacement Surgery
- Thumbs Up For New Pain Relieving Treatment
- Study Identifies Factors That Increase Risk of Falls Among Orthopedic Inpatients
- Study Sheds Light on Aromatase Inhibitor Joint Pain Syndrome
- Patient and Doctor Expectations from Joint Replacement Surgeries Not Always Aligned
- Hospital for Special Surgery Launches Quality Research Center
- Hospital for Special Surgery Launches Study of Injectable Medication to Treat Painful Thumb Arthritis
Education
MD, University of British Columbia, Vancouver
BA, Williams College, Williamstown
Internship
Residency
Fellowship
Certification
Rheumatology
Internal Medicine
State Licensure
Patient Education by Dr. Mandl on HSS.edu
Blog Posts by Dr. Mandl
Editorial Appointments
Assistant Editor, Annals of Internal Medicine
For more publications, please see the PubMed listing.
Clinical Trials
- (Synovial Tissues) Rheumatoid Arthritis (RA) & Early Rheumatoid Arthritis (ERA) tissue study – Recruitment of patients undergoing synovectomy or upper extremity surgery (UES) or synovial biopsies.
- Do Rheumatoid Arthritis Patients Undergoing TKR And THR Require More Transfusions and Have More Pulmonary Disease than OA Controls?
- Perioperative Flare in Rheumatoid Arthritis: Characterization of Clinical and Biologic Features
- Consortium of Early Arthritis Cohorts USA (CATCH-US) – A prospective cohort study of adults with new onset inflammatory arthritis symptoms to understand predictors of optimal outcomes
- A Study of Novel Immune Modulating Biomarkers in Patients with Spondyloarthritis with Axial Involvement
- Biomarkers in Spondyloarthropathies: A Case Control Study
- Lower Extremity Realignment Therapy for the Treatment of Medial Knee Osteoarthritis- A Pilot Study
- Arthroscopic Partial Meniscectomy in Osteoarthritis: A Randomized Control Trial
- A Study of Hyaluronan (Synvisc) for the Treatment of Osteoarthritis in the Thumb: Randomized Control Trial
- Prospective Evaluation of the Clinical and Economic Outcomes of Total Joint Replacement: The HSS Shoulder Arthroplasty Cohort
- Open Label Trial for Treating Carpometacarpal Osteoarthritis: PILOT STUDY - Sub-study on Normal Controls
- Quantitative Assessment of the Synovial Vascularity in Early Inflammatory Arthritis